Metabolic Health / Insulin Sensitivity

Peptides researched for glucose homeostasis, insulin sensitivity, and metabolic-health optimisation. This goal page collects incretin-based therapies (semaglutide, tirzepatide, dulaglutide, exenatide) with glycaemic control as a primary endpoint, alongside GH-axis compounds (tesamorelin, CJC-1295) and mitochondrial peptides (SS-31, humanin) with secondary metabolic data in preclinical and clinical models.